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Optimized Drug Distribution for Pharmacies of 
the National Order of Pharmacists in DR Congo 
using a Multi-Agent Engineering Approach 
Blaise Fyama α & Ruphin Nyami Nyate σ 
Abstract- This paper focuses on a Multi-Agent Oriented 
Engineering for the problem of registration of pharmacists in 
the National Order of Pharmacists (NOP) and the regulation of 
the sale of pharmaceutical products in a distributed 
environment. The behavior of a pharmacist in the practice of 
pharmacy is characterized by interactions with the Provincial 
Council of the Order of Pharmacists (PCOP) of his jurisdiction, 
where he obtains an authorization to practice pharmacy. This  
authorization  is  accompanied  by  the ethical  rules  to  be  
observed  in  order  to  expose medicines on the market. The 
activities of each pharmacist are continuously subject to 
quality control and pharmaceutical vigilance to protect the 
health of the population. In this paper, we focus on the  design 
of a Multi-Agent System (MAS) in order to help the PCOP to 
control the pharmaceutical activity on the one hand, and the 
pharmacists to sell their drugs safely on the other  hand. Our 
MAS is designed based  on the O-MaSE  (Organization based 
Multi- agents System Engineering) method, and our 
methodology took into account the following steps: The 
analysis phase we identified the  goals from the  user's needs  
and  we structured them in a goal hierarchy diagram; followed 
by the application of use cases and associated sequence 
diagram to have  the initial set of roles and communication 
channels; for each role, we assigned the goals to be achieved 
as well as the capabilities required to achieve its goals. In the 
design phase we assigned the roles to specific classes of 
agents, and identified the conversations.  The execution plans 
are also presented in the form of a protocol diagram, where 
we had to ensure that each action appearing in a conversation 
is implemented as a method within the agent   architecture. 
We have also given the architecture and deployment model of 
our MAS. The JADE Framework has been used for the 
implementation of our MAS. 
Keywords: JADE, multi-agent systems, agent modeling, 
O-MaSE, pharmacist.  
I. Introduction 
owadays, the field of Distributed Artificial 
Intelligence provides Software Agents with 
cognitive capabilities comparable to those of 
human beings (reasoning, thinking, learning, and 
deciding). The conquest of the power of this science 
and the evolution of technology is forcing the 
standalone or pre-programmed software development 
process to emancipate itself from the silo for distributed 
systems where  each  application  is  endowed  with  the 
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ability to learn and use the distributed intelligence 
across the network. Each software agent distributed in 
the network is specialized in a given domain and 
interacts with other agents to solve complex problems in 
an environment. The DRC's pharmacy domain is no 
exception as the skills of each pharmacist must be put 
together to produce knowledge bases. This field is 
experiencing a proliferation of pharmaceutical 
dispensaries commonly called "death boxes”, coupled 
with the increase in the counterfeiting of pharmaceutical 
products which endangers the health of the populations. 
The consumer of Congolese pharmaceutical products is 
faced with a total opacity to distinguish a licensed 
pharmacy from a "death box", notwithstanding the rules 
enacted by the PCOP. Our study wants to bring an 
answer to this problem by developing a Multi-Agent 
System made up of intelligent agents able to identify 
each pharmacist, his pharmaceutical activities in order 
to make it public to consumers. Each pharmacist 
registered with the PCOP will obtain exclusive 
authorization to practice pharmacy, which will 
undoubtedly limit the proliferation of unlicensed 
pharmacies. The consumer can now search for a drug 
in the MAS and the intelligent agent will contact qualified 
vendors (pharmacists) to obtain the drug safely. The 
pharmacy domain being complex in its broad spectrum, 
the agents, their interactions and sociability are also 
complex as confirmed by the theory of AMAS (Adaptive 
Multi-agent Systems) which proposes to solve complex 
problems by self-organization for which no algorithmic 
solution is known [1], [2]. Moreover, the autonomous 
agents of our MAS will be subject to ethical rules and 
pharmacists' deontology to make decisions which are 
perceived as locks, or design problems according to an 
agent-centered perspective. This implies the use of 
formal rules to collective ethical issues in multi-agent 
systems proposed in [3], [4], for the achievement of the 
primary goal of protecting the health of the population. 
Several methodologies, allowing the development of this 
kind of system have been proposed. Our choice is 
oriented towards the O-MaSE approach to develop our 
MAS. This methodology is selected for its conceptual 
richness and simplicity. 
Our study is structured around the following 






























































− The related works: this part will allow us to present 
the related works; 
− The design of the MAS for the adherence and 
regulation of the sale of pharmaceutical procedures 
in the market; 
− ADM implementation and simulation. We implement 
under the JADE platform (Java Agent Development 
Framework) a sales negotiation capability between 
intelligent agents. 
II. Related Works 
Membership of the national order of 
pharmacists and pharmaceutical vigilance have been 
the subject of previous studies. The result produced in 
[5] proves that the period of hospitalization or discharge 
of the patient, constitutes a critical stage for the drug 
risk and the notion of drug quality must be a priority 
because only a limited number of patients know how to 
access the accredited pharmacies. This result confirms 
that access to medications requires an intelligent 
system to guide the acquisition of medications. In 
addition, the current technological evolution pushes the 
profession of pharmacy mutation including all 
professionals and pharmacy students who must grasp 
the advances [6]. The research conducted by Benhajji 
[7] have led to a satisfactory result of using a patient-
centered and agent-based approach that minimizes 
waiting times, length of stay, and therefore  costs of 
care, while ensuring quality care for all patients. With 
regard to drug safety and the proliferation of unlicensed 
pharmacies, research has been carried out to dissuade 
offenders B. Allenet and his team [8], [9]. According to 
G. Rousset [10], the distribution of medicines online has 
indirect and negative consequences for patients and 
public health and generates major risks related to the 
difficulty for pharmacists to fulfil their obligations and 
ethics. Other studies deal with the management of 
patients in hospitals. This is notably the case of the work 
of Chuan-Jun and his teammate [11] and others in 2018 
[12].  Other studies have focused their research on the 
ethical and deontological compliance of agents with 
respect to a domain [3], [4]. The problem with all the 
works is that the emphasis has been on reminding the 
agents of the rules established at the domain level even 
if this is not enforced. The literature review previosly 
cited shows the interest given to pharmaceutical 
activities whose consequences are incalculable in 
human health. On the other hand, we did not find any 
papers that addressed the issue of pharmacists' 
membership, pharmaceutical vigilance and the practice 
of pharmacy using the Multi-Agent approach. Multi- 
agent systems (MAS) require interactions between 
agents [13], [14], [15]. These interactions drive learning 
to achieve the common goal [16]. Scott and Wooldridge 
have used agent-oriented methodologies such as MaSE 
[17] ASEME [12] and other appropriate modeling 
techniques. It has been found that some projects use 
multi-agent systems to develop their approach in the 
field of such as industry, tourism, decentralized control 
policies, decision making and coordination. The 
methodology "MaSE" is a seven-step process in two 
phases [18]. In the analysis phase, the identification of 
goals, the application of use cases through sequence 
diagrams and the definition of roles with their required 
competencies. As for the design phase, it defines the 
agent diagram, the protocol diagram (sequences) or 
conversation diagram between classes and deployment 
diagram [18], [19]. In 2012, M. Fethi with his research 
team [20] applied the "O-MaSE" (Organization based 
Multi-agents System Engineering) methodology to solve 
the vehicle touring problem. O-MaSE is an extension to 
the MaSE methodology and completes it with the 
organization dimension. It considers a multi-agent 
system as a social organization. Each agent is a 
member of this organization and plays a specific role 
according to its capacity.  In 2019, Hanane E. Adil Haddi  
and  H. Allali  [13] used the  "MaSE" methodology to 
design a  system to support metacognitive skills to 
learners. Other research works have focused on the 
MaSE methodology as in [21], [12]. This literature on 
MaSE methodology is matched with three main families 
that exist when designing MAS [20]: functional, object 
and agent. The functional approach is generally applied 
to the domain of enterprise information systems by 
treating both the data and processing point of view and 
the aspects going from design to implementation. In the 
object approach, modeling a system consists of 
breaking it down into independent units, each unit 
having its own characteristics (attributes) and operations 
that it can perform (methods). Unlike an agent, an 
object only reacts to a method call and all the situations 
it will face must be taken into account by the designer 
[22].  Moreover, objects cannot have goals nor seek 
satisfaction and the mechanism of sending messages is 
summarized in a simple call of the methods of the class. 
There is no communication language as such between 
the objects in an application. The interaction 
mechanisms are the responsibility of the programmer.  
In turn, the agents have goals that give them autonomy 
of decision with respect to the messages received. In 
[23], it is clearly stated that the MAS reorganizes itself 
continuously according to different scales thanks to the 
movements in the life cycle of the agents. The global 
behavior of the MAS depends on the links between its 
different agents. The behavior will sometimes be regular, 
sometimes chaotic, in all cases non-linear. The 
behavioral model must therefore take into account the 
possibility of non-regularity of the system.  
This distinguishes the agent-based approach 
from those used with functional and object models.  In 
conclusion, the functional and object models are not 
sufficient to design the systems of membership to the 
National Order of Pharmacists and the regulation of the 
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sale of medicines. Because they do not take into 
account the characteristics of autonomy, learning and 
sociability of each component of this system as well as 
their characteristics of complexity and evolution. To 
design our ADM, in the following section 3 we will use 
the O-MaSE methodology [24], [23]. 
III. Design of Our MAS 
The process of joining the national order of 
pharmacists and the process of selling pharmaceutical 
products discussed in this article is very similar to the 
technology of distributed intelligent agents, whose 
centrifugal points are as follows The Provincial Council 
of the Order of Pharmacists is the only body empowered 
to assign a unique national order number to a 
pharmacist to practice pharmacy. Once registered, a 
pharmacist can manufacture molecules and submit 
them to the Congolese Control Office (O.C.C). for quality 
control and conformity. Once certified, the molecule is 
exposed on the market to sellers for consumption. 
Sometimes some drugs are recalled for ineffectiveness 
or for complications that they cause in patients.  It is up 
to the competent authority to decide on the withdrawal 
of these. Whenever a buyer wants to purchase any 
pharmaceutical product, he/she is usually faced with a 
plethora of sellers offering the same product at different 
prices and with different characteristics. Since this 
system is made up of several actors at different levels of 
responsibility, we reaffirm that it fits well with the 
distributed paradigm. In the following we will model the 
process of procurement, quality control and 
compliance, and the sale of pharmaceutical products, in 
this case drugs, in a distributed environment. The 
methodologies for modeling computer systems can be 
classified into three main families: functional, object and 
agent [20]. The functional approach is generally  applied  
to the  field of enterprise information systems by treating 
both the data  and processing point of view and the 
aspects ranging from design to implementation [20] 
[25]. In the object approach, modeling a system 
consists in decomposing it into independent units, each 
unit having its own characteristics (attributes) and 
operations that it can perform (methods). Unlike an 
agent, an object only reacts to a method call and all the 
situations it will face must be taken into account by the 
designer. Moreover, objects cannot have goals nor seek 
satisfaction and the mechanism of sending messages is 
summarized in a simple call of the methods of the class. 
There is no communication language as such between 
the objects in an application. The interaction 
mechanisms are the responsibility of the programmer. In 
turn, the agents have goals that give them autonomy of 
decision with respect to the messages received [21].  In 
[20], it is clearly stated that the MAS reorganizes itself 
continuously according to different scales thanks to the 
movements in the life cycle of the agents. The overall 
behavior of the MAS depends on the links between its 
different agents. The behavior will sometimes be regular, 
sometimes chaotic, in all cases non-linear. The 
behavioral model must therefore take into account the 
possibility of non-regularity of the system. This 
distinguishes the agent-based approach from those 
used with functional and object models. In conclusion, 
the functional and object models are not sufficient to 
model the systems of membership to the National Order 
of Pharmacists and the regulation of the sale of 
medicines. This is because they do not take into 
account the autonomy, learning and sociability 
characteristics of each component of this system as well 
as their complexity and evolution characteristics. To 
model our ADM, we used the O-MaSE methodology 
[24], [23]. O-MaSE (Organization based Muti-agents 
System Engineering) is an extension to the MASE 
methodology that completes it by the organization 
dimension. O-MaSE considers a multi-agent system as 
a social organization. Our methodology has thus 
pursued the following approach: each agent is a 
member of this organization and plays a specific role 
according to its capacity. It is mainly composed of 
models (Goal, Organization, Roles, Ontology, Agent, 
Protocol and Agent State). In the following paragraphs 
we present the main diagrams, namely the goal 
diagram, the role diagram, the agent diagram, the plan 
diagrams and the protocol diagrams. 
a) Development of the Congolese Pharmaceutical 
Universe Goal Map 
The goal diagram of the MaSE methodology is 
an acyclic directed graph where the nodes represent the 
goals and the arcs define a sub-goal relationship [26]. 
Following the problematic of the present article exposed 
previously, the main goal is to protect the health of the 
population by regulating the registration to the PCOP for 
each candidate wishing to practice pharmacy, the 
quality control of medicines intended for sale. This 
primary objective constitutes the overall goal, noted 
Goal 0. Goal 0 is dependent on the achievement of four 
sub-goals which are: 
- Managing the enrollment of new pharmacy 
graduates in PCOP (Goal 1), 
- Management of the supply of medicines in stock 
(Goal2), 
- Consumption of   drug products (Goal3), 
- And the application of pharmaceutical vigilance to 
decide whether or not to use the drug (Goal 4). 
Goal1 is dependent on meeting the objectives 
of several sub goals. Indeed, to enroll a new graduate in 
PCOP, one must first adjudicate the application to 
examine whether the conditions for membership are met 
(Goal1.1). Then, the applicant is identified for enrollment 
in the PCOP (Goal1.2). Goal1.1 depends on the 
achievement of two sub goals, the first of which is to 
select the application for enrollment noted (Goal1.1.1). 






























































And the second goal is the automatic rejection of the 
application by the PCOP noted (Goal1.1.2).  Goal 1.2, 
which concerns «identification of a new pharmacist", is 
dependent on the child goal (Goal 1.2.1) of "accessing 
professional data", the academic curriculum. Goal 1.1.1 
is only achieved if all the elements of the file are 
accepted, i.e. verified, validated by the PCOP noted 
(Goal 1.1.1.1) and also if the notification of the interested 
party of his national order number has taken place 
noted (Goal 1.1.1.2). In addition, Goal 2, "To make 
medicines available on the market», depends on several 
sub goals. In general, the marketing of a drug requires 
prior authorization from the health authorities noted 
(Goal 2.1). This is followed by the  distribution  of 
medicines through  pharmacies (Goal 2.2)  and  the  
submission  of a complete  file to the  PCOP to obtain  a 
license to practice  pharmacy (Goal  2.3).  The (Goal2.1) 
which consists in "authorizing the marketing of a drug" 
entails de facto quality controls of this drug noted 
(Goal2.1.1). And also to consult t h e conformity 
information on the noted drugs (Goal 2.1.2). Goal 2.1.1 
related to "Quality control of medicines" is only achieved 
when the compliance of health specificities is proven 
noted (Goal2.1.1.2) and also when the analysis result 
"prepare notice" has been published, noted 
(Goal2.1.1.1). Goal 2.1.2 "to consult data on medicinal 
products" depends on two sub goals: To consult data 
(technical details) on the medicinal product, this entails 
the extraction of data noted (Goal2.1.2.1) as well as the 
prior identification of the medicinal product concerned 
before it is placed on the market (Goal2.1.2.2). Goal 2.2 
on "Distribution of medicinal products" is achieved if its 
several sub goals are met. The marketing of a batch of 
medicines requires the dissemination of information 
(publish package leaflets and labels) about the   
medicine noted (Goal2.2.1). Then apply the sales policy 
noted (Goal2.2.2). Goal 2.2.2 "Process medicine sales" 
is achieved if quotations have been issued to 
applicants, noted (Goal2.2.2.1) and then if issuing the 
invoice to conclude a sale has taken place, scored 
(Bu2.2.2.2). The Goal3 representing "Consumption of 
medicines" is decomposed into two sub-goals. Indeed, 
the purchase of a drug requires the consultation of the 
list of pharmacists (sellers) available at the PCOP, noted 
(Goal3.1). Then one must be able to carry out the drug 
purchase operation, noted (Goal3.2). Goal3.2 "buy 
product" depends in turn on two child goals. Indeed, the 
purchase of a drug requires the choice of a better offer 
among many others, noted (Goal3.2.1) and, the request 
for quotation from the sellers affiliated to the PCOP 
noted (Goal3.2.2). The goal4 related to "pharmaceutical 
vigilance" depends on several sub-goals. Specifically, it 
starts with the patient experiencing adverse events 
(complications) related to medication and  reporting  the 
information to the health care professional for 
appropriate action, noted  (Goal4.1). Next comes the 
recording of information to decide whether the is harmful 
or not (Goal4.2). Goal 4.2 is achieved if the decision to 
withdraw or not to withdraw the problem drug from the 
market is issued, noted (Goal 4.2.1). And also if 
recommendations have been issued to pharmacists, 
decision makers, consumers, noted (Goal4.2.2). To 
illustrate this textual description, the goal diagram thus 
constructed is presented in Fig. 1. 
b) Application of the use cases of our SMA 
The use case application step of the MaSE 
methodology is crucial to translate the goals (objectives) 
into associated roles and tasks [18], [12]. 
To build the use cases of our MAS, we will refer 
to the requirements described above. The use cases are 
full of  exchanges that  will become  the communication  
elements of our MAS; they  must then  be converted into 
sequence diagrams to describe sequences of events 
between roles and to define the communications 
between the agents that will play these roles (Fig.2). 
 
Fig. 1: Goal diagram of our (MAS) 
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The roles thus identified in this step form the 
initial set of roles used to completely define the system 
roles in the next step [18].  In this sequence diagram 
the boxes at the top of the diagram represent the 
system roles and the arrows between the lines represent 
the events that occur between the roles. Time is 
assumed to flow from the top of the diagram to the 
bottom. 
 
Fig. 2: Pharmacist Enrollment Process Sequence Diagram 
 Role diagram 
The transformation of goals into roles generally 
follows a sequential logic. However, there are situations 
where it is useful to have one role to be responsible for 
several goals. For each goal/sub-goal identified earlier, 
we will have to create a role to realize it. A role can in 
this case achieve two goals at the same time. In order to 
achieve a goal, a role must have at its disposal one (or 
more) "Capabilities". To identify the roles of our 
AMASDM, we based ourselves on the application of use 




































1.1.1.1); Enrollment Applicant 
completes goal
 
2,3; Drug Utilization Decision Maker 
completes goals (4.2.1, 4.2.2); Drug Provider completes 
goals (2.2, 2.2.1); Quality Control completes goals (2.1, 
2.1.1, 2.1.2, 2.1.2.1, 2.1.2.2, 2.1.1.1, 2.1.1.2); Pharmacist 
Locator completes goal1.2.1; Purchase Negotiator 
completes goals (3.1, 3.2, 3.2.1, 3.2.2) finally Sales 
Management completes the goals (2.2.2,  2.2.2.1, 
2.2.2.2). We have mapped goals to individual roles with 
two exceptions. Goals, 1, 2, 3 and 4 were not mapped 
to roles because they were partitioned. The role diagram 
is given in Fig. 3. 
d) Role capacity 
In the following Table 1, the objective is to 
specify the knowledge and skills "Capabilities" or 
"competencies" required for each role.  A capability or 
skill is a know-how,  a mastery of business  rules 
that  an  agent must have  before playing a given role; 
generally  this "know-how" is translated into execution 
plans that  will be translated into (state- transition) 
diagrams (section 3.5) describing the way an agent 
must behave. The following Table 1 describes each role 
and its capabilities required to achieve the goals 
assigned to it: 































































Table I: Role Table 
Goals Roles Capabilities 
Process health information Health reporter 
He/she must be able to "communicate cases": identify 
medications, enter health reports, and transmit complicated cases 
to the decision maker. 
Reporting adverse events 
Consumer of 
medicines 
The consumer must be able to "report adverse events": enter the 
adverse events, enter the medication taken, the date, the time 
taken, the source of the medication. 
Notify reasoned decision 
Order Number 
Notifier 
He is responsible for "informing the decision of file processing" 
more precisely: enter the answer (negative or positive), enter the 
date, place, and motivation of the decision taken by the PCOP. Reject Registration request 
Identify pharmacist PCOP 
Registration 
Validator 
He must be able to "update the membership roster": enter 
administrative, academic, Galen's oath, type of pharmacy to 
practice. 
Ruling on application 
Purpose(1.1) 
Submit file to PCOP 
Applicant for 
registration 
Responsible for collecting the following data: entering the time of 
application, recording the elements of the file, detecting the 
absence of an element of the file. 
Goal(4.2.2) Publish 




It is responsible for the "publication of recommendations": enter 
the name of the product, form, manufacturer, complications 
caused and issue the "List of unauthorized and authorized drugs". To decide on the withdrawal 





He is responsible for the "supply of medicines": enter the product 
name, form, manufacturer, unit price, wholesale price, date of 
manufacture, leaflet, update the product catalog. Goal  (2.2.1): To publish 
notices and labels 
Goal (2.1.1): To address 
product quality 
Quality control 
It must determine the "quality and conformity of the product": to 
seize name, form, series, date manufacture and the date of expiry, 
genealogical form, innocuities. He must detect if the drug is clean 
or unfit for consumption. He must know the list of drugs to be 
withdrawn from the market (expired). 
Goal  (2.1.1.1): to 
prepare analysis result 
Goal(2.1.1.2): to verify 
compliance and 
Goal(2.1.2.2) 




Responsible for collecting the following data:  enter the address 
of the pharmacy, 
List of products, customer comments on this pharmacy, detect the 
status of the pharmacist (active, passive). 
Goal  (2.2.1.1): To 
issue a quote 
 
Goal  (2.2.2.2): To 
issue an invoice 
Sales 
management 
"Master the steps of the sale: enter number, date, and quantity, 
total. It must detect the profit of an outstanding sale or the loss. 
 
Goal  (2.2.2.2): To 
issue an invoice 
Goal(3.1): Consult 
vendor  list Purchasing 
Negotiator 
Responsible for the following operations: inputting drugs to be 
ordered, requesting quotes, negotiating the purchase, accepting 
or rejecting a 
Proposal. 
Goal  (3.2.1):  request for 
quotation 
Goal  (3.2.2):  choose best 
offer  
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e) Agent class diagram 
In this diagram (Fig.5) we want to mod el 
classes of agents capable of possessing all the 
necessary capabilities to play each role. Each class 
represents a model for a type of agent that can be 
instantiated several times according to the needs of the 
system. Indeed, these agent classes describe the global 
organization of the MAS composed of agent classes 
and the conversations between them. An agent class is 
a model for a type of agent in the system and is defined 
in terms of the roles they will play and the conversations 
in which they can participate. If roles are the basis of 
MAS design, agent classes are the building blocks used 
to implement this MAS [4]. 
For the functioning of our system, we have 
retained seven classes of agents that work 
simultaneously: a first agent named "PCOP" having the 
capacities and know-how to play the roles: Validator of 
registration request, Notifier of answers and national 
order numbers of pharmacists and the role of Locator of 
pharmacists. The second class of agent selected is the 
"OCC" agent, having as roles: quality control of 
pharmaceutical products. This agent must have all the 
necessary capabilities to play these roles.  The third 
agent used is the "Pharmacist", whose role is to file with 
the PCOP and to dispense drugs. He/she must have the 
necessary skills to play these roles. The fourth agent 
needed is the "Salesperson" whose roles are: Sales 
Management. The sales agent must have all the 
required capabilities to perform these roles. The fifth 
agent used is the "Buyer" agent having the roles: Buying 
Negotiator. He must also have the necessary 
capabilities to perform this role. The sixth agent used is 
the "Patient" agent whose only role is to report fake 
drugs. Finally, the "Health Professional" agent whose 
role is to decide on the withdrawal of medication and to 
process health alerts. This agent must have the 
capabilities to perform this role. Agent classes are 
similar to object- oriented class diagrams with two main 
differences. First, agent classes are defined by the roles 
they play, not by attributes and methods. Second, all 
relationships between agents classes are captured as 
conversations. The agent class diagram of our ADM is 
also shown in Fig. 5. The rectangles of indicate the 
agent classes and contain the class name and the set of 
roles that each agent plays. The lines with arrows 
identify the conversations and point from the 
conversation initiator to the responder. 
Fig. 3: Role diagram 






























































To consolidate the  textual  description  in  Table  I, the diagram  in  the  following  Fig.4 illustrates  the 
roles and capabilities of our MAS. 
 
Fig. 4: Detailed role-capability diagram 
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Fig. 5: Agent Class Diagram 
f) Diagram of plans 
The creation of roles followed by the 
identification of tasks previously performed requires us 
to specify the behavior of the role by defining the 
algorithmic details of the individual tasks. A role can be 
composed of several tasks that, taken together, define 
the required behavior of that role. Each task runs in its 
own control thread, but can communicate with each 
other. Concurrent tasks are defined in the plan 
diagrams in the following paragraphs and are specified 
as finite state automata, which consist of states and 
transitions. The states encompass the processing that 
takes place internally to the agent while the transitions 
allow communication between agents or between tasks. 
In this section, we detail the capability plan diagrams 
identified earlier, including: PCOP application validation, 
pharmacist location plan, sales management, drug 
control and certification plan, drug purchase negotiation 
plan finally the drug withdrawal plan on the market. 
i. Application Validation» flowchart 
Following the reception of a PCOP membership 
application containing elements to be validated one by 
one of the type receive(validate(elts, condit)) where  elts 
represents the elements of the file each of which 
describes the identity of the applicant (candidate) and 
other administrative information, condit designates the 
conditions required for the validation of the application 
the PCOP agent must verify the presence of each 
element, verify the conditions required to satisfy this 
application among other things (nationality, Galien's 
certificate of oath dating back to two months, 
diplomas,.) in order  to register the pharmacist in the 
membership table by assigning him a number. Upon 
satisfaction of the request, a report from the PCOP is 















































































Fig. 6: "Validation of registration request" plan diagram 
ii. Pharmacist Location Map 
Following the reception of a "receive (select 
Pharmacis())" message requesting the selection of 
the pharmacist, the agent sets itself to the initialization 
state, then retrieves the input search parameter by 
executing the relevant thread. At the end of the 
execution, the agent sends the list of results found 
according to the criterion, otherwise a null result will be 
sent to indicate the absence of the pharmacist. To 
consolidate this description we give below the 
corresponding plan diagram (Fig.7) 
 
Fig. 7: ’Pharmacist location’ plan diagram 
iii. Drug sales management plan 
When a receive(CFP, AID) message is received, 
where  CFP represents  the call for proposal of the 
drugs, AID represents the identifier of the buying agent 
in order to facilitate the communication between the two 
agents. The agent goes to the state "In this report, the 
agent goes to "Wait" for the approval or not of the quote 
by the requester and checks the buyer's answer which 
can be a refusal "REFUSE" or an approval "CONFIRM". 
In the case of acceptance, the agent sends the invoice 
back to the buyer for payment. The following diagram 
(Fig.8) illustrates the sales management plan. 
 
Fig. 8: "Drug Sales Management" Plan Diagram 
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iv. Drug compliance and quality control plan 
The compliance and quality control process 
starts when the agent receives a receive (analyze (medi, 
AID)) message where medi represents the drug 
sample data to be analyzed and AID represents the 
requesting agent who can be a pharmacist who 
submits a molecule to the control or a seller who wants 
to expose on the market the medicines ordered outside 
the country. Everything starts with the analysis of the 
quality of the drug if it requires all the qualities, it passes 
to the state of verification of compliance, if it is also 
compliant, the drug is added to the list already on the 
market otherwise the product is quarantined for 
destruction. This algorithm will run as long as there are 
drugs or molecules to be controlled (Fig. 9). 
 
Fig. 9: Medicines Quality and Compliance Control Plan Diagram 
v. Drug Purchase Negotiation Plan 
When the Buyer agent container is launched, it 
passes through the initialization state where it 
communicates certain technical parameters such as 
the type of service sought, the name of the service, the 
ontology of the service sought and listens to events. 
When it receives a message containing the drug 
services, it switches to the "create call for proposal" state 
while looking for the list of potential sellers of these 
drugs to submit the request. The agent switches to the 
"waiting" state until it receives a sales proposal that will 
be submitted for selection before confirming the 
purchase (Fig.10). 
 
Fig. 10: Drug Purchase Negotiation Plan Diagram 






























































vi. Drug withdrawal plan 
At the launch of the Health Professional agent 
container, this service starts to contact the Patient 
agents to get feedback on the drugs administered to 
him, a series of questions is sent to the existing or 
created patient agents. Upon receipt of a response and 
after the selection of the patient agents involved, the 
Health Professional agent decides whether to withdraw 
a given drug from the market and creates 
recommendations to be made public. The objective is to 
identify ineffective drugs or drugs that create adverse 
effects on the health of the population (Fig.11). 
Fig. 11: "Drug on the market" plan diagram 
g) Protocol diagram 
In this section the objective is to define the 
details of conversations according to the internal details 
of concurrent tasks. A conversation defines a 
coordination protocol between two agents and is 
documented using two communication sequence 
diagrams where we find the initiator a n d the responder 
[27]. Cooperation is necessary when an agent cannot 
achieve its goals without the help of other agents. This 
situation is common even in primitive species. The goals 
requiring cooperation can be coordination, negotiation, 
communication between agents. These conversations 
are defined according to rules called "cooperation 
protocols" or "Conversation protocols", which indicate 
the allowed sequences of messages. A wide variety of 
protocols exist. Examples are the "Contract Net 
Protocol" for bidding and the generic protocols 
proposed by FIPA [28], such as "Dutch auction 
protocol" and "Iterated Contract Net Protocol". In our 
approach we use the “Contract Net Protocol" for inter-
agent negotiation [28] with the FIPA 2002 extension 
consisting of successive rounds of proposal 
confirmations and refusals [27]. The "Contract Net 
Protocol" is a negotiation mechanism between two types 
of agents: contractor and manager. It allows a manager, 
after some exchanges with a group of agents, to retain 
the services of an agent called contractor for the 
execution of a contract task. This protocol is qualified as 
a "mutual selection" type since to sign a contract, the 
chosen agent must commit to the manager for the 
execution of the task and the manager selects only the 
agent having provided the most advantageous 
proposal. The original version of the protocol has three 
main steps: the call for bids, the submission of 
proposals and the award of the contract. A protocol 
linking two agents is described by a sequence diagram 
that represents the different interactions between the 
entities by indicating the order of messages exchanged. 
In our case, we have five types of communication 
between the different agents. The first concerns the 
processing of a new PCOP registration request.  The 
second deals with the identification of pharmacists, the 
third deals with the control of drugs, the fourth deals 
with the negotiation of purchases and finally the fifth 
deals with pharmacovigilance. 
i. "PCOP Application Processing" Protocol Diagram 
After receiving a new application for registration 
D, CG, ID, AID, where D represents the university 
degrees obtained, CG means the certificate of Galen, ID 
means the identity document of the applicant and AID 
represents the unique identifier of the agent and its 
location, the PCOP agent sends a response to the 
applicant which can be a refusal in case the conditions 
are not met otherwise an acceptance of the application 
for registration. At the same time, a report is sent to the 
CNOP for a possible attribution of a national order 
number in case of an acceptance, otherwise a simple 
information report of the rejection. Acceptance of the 
application results in the assignment of a national order 
number to the pharmacist: transmit national number 
(NN), the PCOP agent notifies the pharmacist 
concerned of his registration with the national order of 
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Fig. 12: Protocol diagram "Processing of the PCOP registration request 
ii. Protocol Diagram "Identification of Pharmacist 
Services 
After the PCOP agent approves the requests, 
the PCOP agent updates the table of skills, services, 
and locations of each registered pharmacist's pharmacy 
(Fig. 13). The request for publication of services 
promotes their services (S, AID) where S designates the 
services offered (drugs) by this pharmacist and AID 
indicates the location, address of the requesting agent. 
 
Fig. 13: Protocol diagram "identification of pharmacist services" 
iii. Quality control protocol diagram 
Following the reception of a drug sample to be 
analyzed (E, Q, AID) where E represents the sample to 
be analyzed, Q designates the drug and AID represents 
the address and identifier of the pharmacist agent. The 
OCC agent authorizes or does not authorize the market 
exposure of the drug according to the analysis result 
(Fig.14) 
 
Fig. 14: Quality control protocol diagram" 






























































iv. Drug purchase negotiation" protocol diagram 
Following the reception of an alert of a medical 
prescription (M, Q) where M indicates the drugs to be 
bought and Q, the prescribed quantity of a Consumer 
agent who informs the Buyer agent by this prescription. 
The Buyer agent has to look for a potential pharmacist 
(seller) to buy these drugs safely. Upon this, the Buyer 
agent issues a query to the PCOP to find sellers who 
have these drugs (S, AID) where S denotes the type of 
service that will be used as a pharmacist selection 
criterion and AID denotes the location and ID of 
the Buyer agent. The PCOP agent provides the latter 
with a list of potential sellers found. The Buyer Agent 
now issues a call for proposal (request for quote) to the 
sellers received for a possible proposal or refusal. In 
case of a proposal, the buyer must choose one of the 
best offers (accept proposal) or reject the proposal 
(Fig.15) 
 
Fig. 15: "Drug purchase negotiation" protocol diagram 
v. Pharmaceutical vigilance management" protocol 
diagram 
Following the receipt of an alert or complication 
due to the use of a drug or ineffectiveness or adverse 
reactions from a patient agent, the health professional 
agent must inform the agents: Vendor, Pharmacist and 
Consumer of the withdrawal of a problem drug from 
circulation (Fig. 16). 
 
Fig. 16: Pharmaceutical vigilance Management protocol diagram 
h) Agent architecture of our MAS 
Starting from the agent class diagram 
described above, we will present the agent architecture 
of our SMA. It is worth recalling that our ADM allows us 
to identify the pharmacist before practicing his 
profession, to control his products to ensure that they 
comply with the standards, to negotiate the sale 
between the buyer and the seller. This results in a 
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permanent "pharmaceutical vigilance" control of the 
effects of drugs on the market. The proposed solution 
also makes it possible to manage unforeseen events 
that may occur, such as the arrival of a new pharmacy 
graduate or the appearance of a complication due to 
the use of a drug. The architecture defined (Fig. 17) 
provides for the use of seven agents: PCOP agent, 
Pharmacist agent, OCC agent, Sales agent, Buyer 
agent, Patient agent, and Healthcare Professional agent. 
 
Fig. 17: Architecture diagram of our MAS 
Deployment architecture of our MAS  
This paragraph defines the deployment of our 
ADM before its implementation because agents usually 
need information on the deployment diagram, 
such as a host name or an address, for 
communications that usually incur a cost in the network. 
Fig. 18 shows a deployment diagram for the National 
Order of Pharmacists membership and drug sales 
system. The cube nodes represent the agents while the 
connection lines represent the actual conversations 
between agents. Agents are identified by their class 
name in the form name-instance: class. The dotted 
boxes define the processing platforms. To reduce the 
communication load, we preferred to deploy the Buyer 
agents as well as the consumer on the same machine 
and the Seller, Pharmacist agents on the same machine. 
The rest of the agents are each deployed in a machine 
connected to the network in order to guarantee the 
advantages of the distribution obtained by using the 
multi-agent paradigm.  
 
Fig. 18: Deployment architecture of our MAS 































































IV. Implementation of the Proposed 
Solution under Jade 
Given this multitude of multi-agent development 
tools, we chose the JADE Framework. JADE (Java 
Agent Development Framework) is a multi-agent 
platform developed in Java by CSELT (Gruppo Telecom 
Research Group, Italy) a n d which aims at facilitating 
the development of multi-agent applications in 
compliance with FIPA specifications [29], [27]. The 
JADE agent platform includes all mandatory 
components that control an ADM. These components 
are: the Agent Communication Channel (ACC) 
which provides the route for basic interactions between 
agents inside and outside the platform, the Agent 
Management System (AMS) which is the agent 
management system, and the Directory Facilitator (DF) 
which provides a yellow page service to the multi-agent 
platform. All communication between agents is 
performed by FIPA-ACL messages [27]. The agent 
platform can be distributed over several servers. A 
single Java application, and thus a single Java Virtual 
Machine (JVM), is executed on each server. Each JVM is 
an agent container that provides a complete 
environment for agent execution and allows multiple 
agents to run in parallel on the same server. The 
communication architecture provides flexible and 
efficient message passing. JADE creates and controls a 
queue of incoming messages for each agent. It should 
also be noted that each platform launched and all the 
agents that make it up are controlled by the RMA 
(Remote Management Agent). The choice of JADE is 
justified by the fact that the agents can communicate 
dynamically with each other, which is consistent with the 
multi-agent orthodoxy.  For the sake of simplicity, we 
will limit ourselves in this paper to the implementation of 
the "Negotiation of the purchase of drugs” capability in 
our MAS.  
Fig. 19: JADE platform software architecture [27] 
a) The "Negotiate Drug Purchases" Capacity 
Additional programming platforms were used 
JADE [11], NetBeans [30], a jade.jar API [31]. The 
purchase of drugs in our MAS involves interaction 
requires a negotiation capability between the buyer and 
sellers. The buying agent is placed in a different 
container than the seller or the consumer. Note that 
there can be as many agents on the same container 
depending on the needs. In the detailed protocol 
diagram (Figure 20) where each agent is located in a 
single container with the possibility of migrating from 
one container to another without losing its 
capabilities. The main container "MainContainer" 
contains the main modules AMS and DF respectively 
the identifier of the agents and the facilitator in the 
search for services; we also find two containers: 
Container 0 which contains the first salesman 
(pharmacist1) and Container 1 for the second 
pharmacist. Containers 2 and 3 are reserved for the 
buyer and the seller respectively. Each selling agent 
publishes his services to the DF and listens for buyer 
events; the buying agent simply contacts the DF to find 
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Fig. 20: Detailed protocol diagram of the "Drug Purchase Negotiation" capability 
In the following Fig.21, it is clearly demonstrated 
the discrete communication between the agents 
involved in this drug purchase negotiation scheme in our 
AMS. Using the Sniffer agent we decided to spy on a 
group of agents (Consumer, Buyer, a first pharmacist 
named DE SIFA and another named DEMBO, an AMS 
agent and DF). Each message leaving or going to this 
group is captured and displayed on the sniffer interface. 
We can see the message leaving from the consumer to 
the buyer, from the buyer agent to DF and vice versa. 
Note also that a click on the link of a message gives the 
details on the content of the message. 
 
Fig. 21: Interface de l’agent Sniffer de notre MAS 































































This paper aimed at designing a Multi-Agent 
System for the regulation of drug sales in order to 
secure the health of the population. Indeed, the 
designed MAS allows the registration of pharmacists in 
the Provincial Council of Pharmacists, the control of the 
quality and conformity of drugs before their exposure on 
the market, the negotiation of sales between agents and 
the follow-up of pharmaceutical vigilance. Our MAS is 
composed of seven classes of agents: Pharmacist, 
Vendor, Buyer, OCC, PCOP, Healthcare Professional 
and Patient who communicate with each other using the 
"Contract Net Protocol" with the FIPA 2002 extension. 
The modeling of the system was done according to the 
O-MaSe methodology. The implementation of the 
agents as well as the interactions between them were 
carried out under the JADE platform. In the near future, it 
would be imperative to address issues of quality control 
and drug design, certification of pharmacy degrees to 
ensure the health of the population. 
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